NCT06724263 2024-12-09A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsTasly Biopharmaceuticals Co., Ltd.Phase 2 Not yet recruiting120 enrolled
NCT06078670 2023-10-12PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid TumorsFujian Cancer HospitalPhase 1/2 Not yet recruiting96 enrolled